Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase-2 expression in canine appendicular osteosarcomas.

Marie N Mullins1, Susan E Lana, William S Dernell

  • 1Animal Cancer Center, Departments of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA. mmullins@colostate.edu

Journal of Veterinary Internal Medicine
|January 11, 2005
PubMed
Summary

Cyclooxygenase-2 (COX-2) is frequently expressed in canine osteosarcoma. Strong COX-2 expression in canine osteosarcomas is linked to significantly shorter survival times, suggesting its potential as a prognostic marker.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ZnO-Hydroxyapatite-Coated Ti-6Al-4V With Curcumin and Ginger Extract for Load-Bearing Implants.

Journal of the American Ceramic Society. American Ceramic Society·2026
Same author

Comparative genomic and clinicopathological analysis uncovers contrasting molecular profiles of canine and human thyroid carcinomas.

Communications biology·2025
Same author

Author Correction: Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions.

Scientific reports·2024
Same author

Canine salivary gland carcinoma treated with stereotactic body radiation therapy: a retrospective case series.

Frontiers in veterinary science·2023
Same author

Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions.

Scientific reports·2023
Same author

Cardiac Rhabdomyoma in Four Göttingen Minipigs.

Toxicologic pathology·2023

Area of Science:

  • Veterinary Oncology
  • Cancer Biology
  • Immunohistochemistry

Background:

  • Osteosarcoma is the most common primary bone tumor in dogs, often leading to fatal metastasis.
  • Targeted therapies are crucial for improving survival times in canine osteosarcoma.
  • Cyclooxygenase-2 (COX-2) plays a role in various cancers, but its function in mesenchymal tumors like osteosarcoma is not well understood.

Purpose of the Study:

  • To investigate cyclooxygenase-2 (COX-2) expression in canine appendicular osteosarcomas.
  • To determine if COX-2 expression intensity correlates with clinicopathologic outcomes in dogs with osteosarcoma.

Main Methods:

  • Immunohistochemical analysis of COX-2 expression in 44 canine appendicular osteosarcomas.
  • Correlation of COX-2 staining intensity with overall survival time.

Related Experiment Videos

Main Results:

  • COX-2 was expressed in 77.3% of canine osteosarcomas.
  • The majority of positive cases (88%) showed poor to moderate COX-2 staining.
  • Dogs with strong COX-2 expression had significantly reduced overall survival (median 86 days) compared to those with negative, poor, or moderate expression.

Conclusions:

  • COX-2 is commonly expressed in canine osteosarcoma.
  • Strong COX-2 expression is a negative prognostic indicator in canine osteosarcoma.
  • Further research is needed to explore COX-2 as a prognostic marker and therapeutic target.